Autor segons l'article: Bielska-Lasota M, Rossi S, Krzy?ak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P, EUROCARE-5 Working Group
Departament: Medicina i Cirurgia
Autor/s de la URV: Galceran Padrós, Jaume Josep Maria
Paraules clau: Survival Stage at diagnosis Population-based study Morphology Europe Cervical cancer stage at diagnosis population-based study morphology europe cervical cancer
Resum: © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age. Methods: We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosis were computed. Results: EE women were older and less commonly diagnosed with glandular tumours. Proportions of local stage cancers were similar across Europe, while morphology- and stage-specific RS (especially for non-metastatic disease) were lower in Eastern Europe. Adjusting for age and morphology, excess risk of local stage CC death for EE patients remained higher than that for other European women. Conclusion: Stage, age and morphology alone do not explain worse survival in Eastern Europe: less effective care may play a role, probably partly due to fewer or inadequate resources being allocated to health care in this area, compared to the rest of Europe.
Àrees temàtiques: Saúde coletiva Odontología Obstetrics and gynecology Obstetrics & gynecology Nutrição Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Materiais Interdisciplinar Geociências General medicine Farmacia Engenharias iii Enfermagem Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Biodiversidade Arquitetura, urbanismo e design
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 09320067
Adreça de correu electrònic de l'autor: jaumejosepmaria.galceran@urv.cat
Data d'alta del registre: 2023-02-19
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
Enllaç font original: https://link.springer.com/article/10.1007/s00404-019-05412-5
Referència a l'article segons font original: Archives Of Gynecology And Obstetrics. 301 (2): 591-602
Referència de l'ítem segons les normes APA: Bielska-Lasota M, Rossi S, Krzy?ak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P, EUROCARE-5 Workin (2020). Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Archives Of Gynecology And Obstetrics, 301(2), 591-602. DOI: 10.1007/s00404-019-05412-5
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI de l'article: 10.1007/s00404-019-05412-5
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2020
Tipus de publicació: Journal Publications